Eplerenone (Pharmacia)

Liew, Danny, Martin, Jennifer and Krum, Henry (2003) Eplerenone (Pharmacia). Current Opinion in Investigational Drugs, 4 3: 316-322.

Author Liew, Danny
Martin, Jennifer
Krum, Henry
Title Eplerenone (Pharmacia)
Journal name Current Opinion in Investigational Drugs   Check publisher's open access policy
ISSN 1472-4472
Publication date 2003-03
Sub-type Critical review of research, literature review, critical commentary
Volume 4
Issue 3
Start page 316
End page 322
Total pages 7
Place of publication London, U.K.
Publisher Current Drugs
Language eng
Subject 1115 Pharmacology and Pharmaceutical Sciences
Formatted abstract
Pharmacia Corp (formerly GD Searle & Co) is developing eplerenone, an aldosterone receptor antagonist, as a potential treatment for congestive heart failure and systemic hypertension. The compound has been registered for hypertension and Pharmacia plans to submit a supplemental NDA for congestive heart failure in the first half of 2003 based on positive results from a phase III clinical trial.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: Excellence in Research Australia (ERA) - Collection
School of Medicine Publications
Version Filter Type
Citation counts: Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Thu, 08 Apr 2010, 11:11:36 EST by Jon Swabey on behalf of Faculty Of Health Sciences